Comparative efficacy of 2 zotarolimus-eluting stent generations: Resolute versus endeavor stents in patients with coronary artery disease

American Heart Journal

Volumn 165, Issue 1, 2013, Pages 80-86

  Tada, Tomohisa ^a   Byrne, Robert A ^a   Cassese, Salvatore ^a   King, Lamin ^a   Schulz, Stefanie ^a   Mehilli, Julinda ^a   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDEAVOR ZOTAROLIMUS-ELUTING STENT; RESOLUTE ZOTAROLIMUS-ELUTING; UNCLASSIFIED DRUG; ZOTAROLIMUS;

AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEATH; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RISK ASSESSMENT; SIROLIMUS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84870925467     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.10.019     Document Type: Article

References (21)

1. K. Udipi, M. Chen, and P. Cheng Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent J Biomed Mater Res A 85 2008 1064 1071
2. I.T. Meredith, S. Worthley, and R. Whitbourn The next-generation Endeavor Resolute stent: 4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial EuroIntervention 3 2007 50 53
3. I.T. Meredith, S. Worthley, and R. Whitbourn Clinical and angiographic results with the next-generation resolute stent system: A prospective, multicenter, first-in-human trial JACC Cardiovasc Interv 2 2009 977 985
4. I.T. Meredith, S.G. Worthley, and R. Whitbourn Long-term clinical outcomes with the next-generation Resolute Stent System: A report of the two-year follow-up from the RESOLUTE clinical trial EuroIntervention 5 2010 692 697
5. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
6. S. Silber, S. Windecker, and P. Vranckx Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All comers trial Lancet 377 2011 1241 1247
7. R.A. Byrne, A. Kastrati, and K. Tiroch 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based cypher and endeavor drug-eluting stents J Am Coll Cardiol 55 2010 2536 2543
8. S. Massberg, R.A. Byrne, and A. Kastrati Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: The intracoronary stenting and angiographic results: Test efficacy of sirolimus- and probucol-eluting versus zotarolimus-eluting stents (ISAR-TEST 5) trial Circulation 124 2011 624 632
9. R.A. Byrne, J. Mehilli, and R. Iijima A polymer-free dual drug-eluting stent in patients with coronary artery disease: A randomized trial vs. Polymer-based drug-eluting stents Eur Heart J 30 2009 923 931
10. R.A. Byrne, A. Kastrati, and S. Kufner Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: The intracoronary stenting and angiographic results: Test efficacy of 3 limus-eluting stents (ISAR-TEST-4) trial Eur Heart J 30 2009 2441 2449
11. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm294951.htm "Resolute MicroTrac Zotarolimus-Eluting Coronary Stent System (Resolute MicroTrac) and Resolute Integrity Zotarolimus-Eluting Coronary Stent System (Resolute Integrity) - P110013".
12. J. Fajadet, W. Wijns, and G.J. Laarman Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine- encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806
13. A.C. Yeung, M.B. Leon, and A. Jain Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: The RESOLUTE US clinical trial J Am Coll Cardiol 57 2011 1778 1783
14. G. Guagliumi, H. Ikejima, and V. Sirbu Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: The LongOCT study (Optical Coherence Tomography in Long Lesions) JACC Cardiovasc Interv 4 2011 778 785
15. J. Mehilli, R.A. Byrne, and A. Wieczorek Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis Eur Heart J 29 2008 1975 1982
16. P.W. Serruys, G. Sianos, and A. Abizaid The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: The paclitaxel in-stent controlled elution study (PISCES) J Am Coll Cardiol 46 2005 253 260
17. F.C. Tanner, Z.Y. Yang, and E. Duckers Expression of cyclin-dependent kinase inhibitors in vascular disease Circ Res 82 1998 396 403
18. C. von Birgelen, M.W. Basalus, and K. Tandjung A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: The TWENTE trial J Am Coll Cardiol 59 2012 1350 1361
19. T. Uchida, J. Popma, and G.W. Stone The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: A critical assessment of "oculostenotic" reintervention in patients with intermediate lesions JACC Cardiovasc Interv 3 2010 403 411
20. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
21. Cassese S, Byrne R, Tada T, et al. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials Eur Heart J. [in press].